Abbott Laboratories (ABT)

AI-powered earnings prediction for Abbott Laboratories (ABT).

101.83
-0.46%
USD, 1 day ago
Market Cap
176.93B
Google

Company Overview

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. The company also provides cancer screening and diagnostic test products. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

Sector
Healthcare
Industry
Medical Devices
Phone
224 667 6100
Headquarters
100 Abbott Park Road
Abbott Park, IL, 60064-6400
United States
Full-Time Employees
115,000

Key Metrics

P/E Ratio (TTM)
27.37
Forward P/E
16.68
Price to Book
3.39
Beta
0.78
Profit Margin
14.72%
Gross Margin
56.66%
Return on Equity
12.96%
Return on Assets
6.63%
Earnings Growth
-80.90%
Revenue Growth
4.40%
Dividend Yield
245.00%
Dividend Rate
$2.52

Financial Health

Total Cash
$8.94B
Total Debt
$14.14B
Debt to Equity
26.79
Current Ratio
1.58
Free Cash Flow
$6.29B
Operating Cash Flow
$9.57B

Analyst Recommendations

Target Price (Mean)
$132.28
Target High
$158.00
Target Low
$113.00
Recommendation
buy
Analyst Coverage
25 Analysts

Trading Ideas

Related Stocks

Will ABT Beat Earnings? AI Prediction next earnings | TradAdvisor